Drugs interactions for Pemazyre®

  • 23 Major drug interactions (including ingredients like Abametapir, Apalutamide, Bexarotene)
  • 97 Moderate drug interactions (including ingredients like Amiodarone, Aprepitant, Articaine)
  • 5 Minor drug interactions (including ingredients like Metreleptin, Omaveloxolone, Somatrogon)
125 interactions for Pemazyre®
A therapy excluded from this list of known interactions does not necessarily mean that no interactions exist between that therapy and and Pemazyre®.
Abametapir
The serum concentration of Pemigatinib can be increased when it is combined with Abametapir.
Apalutamide
The metabolism of Pemigatinib can be increased when combined with Apalutamide.
Bexarotene
The metabolism of Pemigatinib can be increased when combined with Bexarotene.
Bosentan
The metabolism of Pemigatinib can be increased when combined with Bosentan.
Carbamazepine
The metabolism of Pemigatinib can be increased when combined with Carbamazepine.
Dexamethasone
The metabolism of Pemigatinib can be increased when combined with Dexamethasone.
Dexamethasone acetate
The metabolism of Pemigatinib can be increased when combined with Dexamethasone acetate.
Echinacea
The metabolism of Pemigatinib can be increased when combined with Echinacea.
Efavirenz
The metabolism of Pemigatinib can be increased when combined with Efavirenz.
Enzalutamide
The metabolism of Pemigatinib can be increased when combined with Enzalutamide.
Etravirine
The metabolism of Pemigatinib can be increased when combined with Etravirine.
Fosphenytoin
The metabolism of Pemigatinib can be increased when combined with Fosphenytoin.
Lumacaftor
The metabolism of Pemigatinib can be increased when combined with Lumacaftor.
Midostaurin
The metabolism of Pemigatinib can be increased when combined with Midostaurin.
Mitotane
The metabolism of Pemigatinib can be increased when combined with Mitotane.
Modafinil
The metabolism of Pemigatinib can be increased when combined with Modafinil.
Nafcillin
The metabolism of Pemigatinib can be increased when combined with Nafcillin.
Pentobarbital
The metabolism of Pemigatinib can be increased when combined with Pentobarbital.
Phenobarbital
The metabolism of Pemigatinib can be increased when combined with Phenobarbital.
Phenytoin
The metabolism of Pemigatinib can be increased when combined with Phenytoin.
Primidone
The metabolism of Pemigatinib can be increased when combined with Primidone.
Rifampin
The metabolism of Pemigatinib can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Pemigatinib can be increased when combined with Rifapentine.
Amiodarone
The metabolism of Pemigatinib can be decreased when combined with Amiodarone.
Aprepitant
The metabolism of Pemigatinib can be decreased when combined with Aprepitant.
Articaine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Articaine.
Atazanavir
The metabolism of Pemigatinib can be decreased when combined with Atazanavir.
Avanafil
The serum concentration of Avanafil can be increased when it is combined with Pemigatinib.
Benzocaine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Benzocaine.
Benzyl alcohol
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Benzyl alcohol.
Berotralstat
The metabolism of Pemigatinib can be decreased when combined with Berotralstat.
Bupivacaine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Bupivacaine.
Butamben
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Butamben.
Capsaicin
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Capsaicin.
Cenobamate
The serum concentration of Pemigatinib can be decreased when it is combined with Cenobamate.
Chloroprocaine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Chloroprocaine.
Cinchocaine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Cinchocaine.
Ciprofloxacin
The metabolism of Pemigatinib can be decreased when combined with Ciprofloxacin.
Clarithromycin
The metabolism of Pemigatinib can be decreased when combined with Clarithromycin.
Clozapine
The metabolism of Pemigatinib can be decreased when combined with Clozapine.
Cocaine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Cocaine.
Conivaptan
The metabolism of Pemigatinib can be decreased when combined with Conivaptan.
Curcumin
The metabolism of Pemigatinib can be decreased when combined with Curcumin.
Cyclosporine
The metabolism of Pemigatinib can be decreased when combined with Cyclosporine.
Dabrafenib
The serum concentration of Pemigatinib can be decreased when it is combined with Dabrafenib.
Danazol
The metabolism of Pemigatinib can be decreased when combined with Danazol.
Darbepoetin alfa
The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Pemigatinib.
Darunavir
The metabolism of Pemigatinib can be decreased when combined with Darunavir.
Desvenlafaxine
The metabolism of Pemigatinib can be decreased when combined with Desvenlafaxine.
Diltiazem
The metabolism of Pemigatinib can be decreased when combined with Diltiazem.
Diphenhydramine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Diphenhydramine.
Dronedarone
The metabolism of Pemigatinib can be decreased when combined with Dronedarone.
Dyclonine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Dyclonine.
Econazole
The metabolism of Pemigatinib can be decreased when combined with Econazole.
Elvitegravir
The metabolism of Pemigatinib can be decreased when combined with Elvitegravir.
Epcoritamab
The serum concentration of Pemigatinib can be increased when it is combined with Epcoritamab.
Ergotamine
The metabolism of Pemigatinib can be decreased when combined with Ergotamine.
Erythromycin
The metabolism of Pemigatinib can be decreased when combined with Erythromycin.
Erythropoietin
The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Pemigatinib.
Etrasimod
The risk or severity of immunosuppression can be increased when Pemigatinib is combined with Etrasimod.
Fedratinib
The serum concentration of Pemigatinib can be increased when it is combined with Fedratinib.
Fluconazole
The metabolism of Pemigatinib can be decreased when combined with Fluconazole.
Fluvoxamine
The metabolism of Pemigatinib can be decreased when combined with Fluvoxamine.
Fosnetupitant
The metabolism of Pemigatinib can be decreased when combined with Fosnetupitant.
Fusidic acid
The metabolism of Pemigatinib can be decreased when combined with Fusidic acid.
Glofitamab
The serum concentration of Pemigatinib can be increased when it is combined with Glofitamab.
Haloperidol
The serum concentration of Haloperidol can be increased when it is combined with Pemigatinib.
Indinavir
The metabolism of Pemigatinib can be decreased when combined with Indinavir.
Isavuconazonium
The metabolism of Pemigatinib can be decreased when combined with Isavuconazonium.
Isoniazid
The metabolism of Pemigatinib can be decreased when combined with Isoniazid.
Isradipine
The metabolism of Pemigatinib can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Pemigatinib can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Pemigatinib can be increased when it is combined with Ivacaftor.
Ivosidenib
The metabolism of Pemigatinib can be increased when combined with Ivosidenib.
Ketoconazole
The metabolism of Pemigatinib can be decreased when combined with Ketoconazole.
Levoketoconazole
The metabolism of Pemigatinib can be decreased when combined with Levoketoconazole.
Lidocaine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Lidocaine.
Linagliptin
The metabolism of Pemigatinib can be decreased when combined with Linagliptin.
Lonafarnib
The metabolism of Pemigatinib can be decreased when combined with Lonafarnib.
Lopinavir
The metabolism of Pemigatinib can be decreased when combined with Lopinavir.
Luliconazole
The metabolism of Pemigatinib can be decreased when combined with Luliconazole.
Mavacamten
The serum concentration of Pemigatinib can be decreased when it is combined with Mavacamten.
Meloxicam
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Meloxicam.
Mepivacaine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Mepivacaine.
Methimazole
The metabolism of Pemigatinib can be decreased when combined with Methimazole.
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Pemigatinib.
Miconazole
The metabolism of Pemigatinib can be decreased when combined with Miconazole.
Milnacipran
The metabolism of Pemigatinib can be decreased when combined with Milnacipran.
Nefazodone
The metabolism of Pemigatinib can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Pemigatinib can be decreased when combined with Nelfinavir.
Netupitant
The metabolism of Pemigatinib can be decreased when combined with Netupitant.
Nicardipine
The metabolism of Pemigatinib can be decreased when combined with Nicardipine.
Nilotinib
The metabolism of Pemigatinib can be decreased when combined with Nilotinib.
Oxybuprocaine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Oxybuprocaine.
Phenol
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Phenol.
Pitolisant
The serum concentration of Pemigatinib can be decreased when it is combined with Pitolisant.
Posaconazole
The metabolism of Pemigatinib can be decreased when combined with Posaconazole.
Pramocaine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Pramocaine.
Prilocaine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Prilocaine.
Primaquine
The metabolism of Pemigatinib can be decreased when combined with Primaquine.
Procaine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Procaine.
Proparacaine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Proparacaine.
Ribociclib
The metabolism of Pemigatinib can be decreased when combined with Ribociclib.
Ritlecitinib
The serum concentration of Pemigatinib can be increased when it is combined with Ritlecitinib.
Ritonavir
The serum concentration of Pemigatinib can be increased when it is combined with Ritonavir.
Ropivacaine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Ropivacaine.
Saquinavir
The metabolism of Pemigatinib can be decreased when combined with Saquinavir.
Satralizumab
The serum concentration of Pemigatinib can be decreased when it is combined with Satralizumab.
Sotorasib
The serum concentration of Pemigatinib can be decreased when it is combined with Sotorasib.
Stiripentol
The metabolism of Pemigatinib can be decreased when combined with Stiripentol.
Telithromycin
The metabolism of Pemigatinib can be decreased when combined with Telithromycin.
Telotristat ethyl
The serum concentration of Pemigatinib can be decreased when it is combined with Telotristat ethyl.
Tetracaine
The risk or severity of methemoglobinemia can be increased when Pemigatinib is combined with Tetracaine.
Tioconazole
The metabolism of Pemigatinib can be decreased when combined with Tioconazole.
Tipranavir
The metabolism of Pemigatinib can be decreased when combined with Tipranavir.
Tucatinib
The metabolism of Tucatinib can be decreased when combined with Pemigatinib.
Venetoclax
The metabolism of Pemigatinib can be decreased when combined with Venetoclax.
Verapamil
The metabolism of Pemigatinib can be decreased when combined with Verapamil.
Voriconazole
The metabolism of Pemigatinib can be decreased when combined with Voriconazole.
Ziprasidone
The metabolism of Pemigatinib can be decreased when combined with Ziprasidone.
Metreleptin
The metabolism of Pemigatinib can be increased when combined with Metreleptin.
Omaveloxolone
The serum concentration of Pemigatinib can be decreased when it is combined with Omaveloxolone.
Somatrogon
The metabolism of Pemigatinib can be increased when combined with Somatrogon.
Vadadustat
The serum concentration of Pemigatinib can be increased when it is combined with Vadadustat.
Viloxazine
The metabolism of Pemigatinib can be decreased when combined with Viloxazine.